The global peritoneal dialysis market size to reach USD 4.5 billion, exhibiting an absolute growth of over 44% during the forecast period. Rise in demand for home peritoneal dialysis treatment, increasing demand for automated dialysis and emergence of on-demand PD will drive the market growth during the forecast period.
The industry is growing due to the growing elderly population that increases the risk of kidney diseases and the high adoption of several dialysis treatment options, especially PD. The scarce availability of organ donors has led to increasing long-term application of PD, seeing how the wait for a kidney transplantation can take up to a few years. This increasing patient population, lowering the number of organ transplants, and favourable government initiatives are boosting the market growth.
The viral awareness of PD among end-users is boosting the demand for PD products. Moreover, improving healthcare infrastructure in developing as well as developed countries increased their focus on adopting advanced APD products that will allow free movement for an entire day and enable dialysis treatment at night during sleep.
- The PD solution segment is expected to observe a revenue of over $2.4 billion by 2025 on account of the presence of characteristics such as acidic pH, high glucose concentrations, and hyperosmolarity in PD solutions.
- The CAPD segment is likely to observe an incremental growth of over $1 billion by 2025.
- The chronic kidney failure segment is projected to grow at the highest CAGR during the forecast period because of the high prevalence of CKF and the outbreak of the COVID-19 pandemic.
- The home healthcare setting segment is likely to register a revenue of close to $2.8 billion by 2025 driven by the increasing patient pool and the growing elderly population.
- The APAC region is expected to grow at the highest CAGR of close to 8.5% during the period 2019–2025. The growth can be attributed to the highest chronic kidney disease prevalence in the world.
GLOBAL PERITONEAL DIALYSIS MARKET TRENDS AND DRIVERS
Favorable government initiatives such as attractive reimbursement policies and increasing demand for technologically-advanced procedures are fueling the market. Patients with End-Stage Renal Disease (ESRD) constitute less than 1% of the total Medicare population but account for nearly 7% of dollars spent. There has been increasing focus on Medicare expenditures for ESRD. In 2011, the expanded prospective payment system for the Medicare ESRD program was implemented, and this likely spurred the growth seen in home dialysis modalities, particularly PD, over the past several years. The report provides a detailed analysis of trends, drivers, and restraints impacting the global peritoneal dialysis market.
MARKET SEGMENTATION - INSIGHTS BY PRODUCT
The global PD solution segment is expected to grow at a CAGR of over 6% during the period 2019–2025. The growing interest to manufacture new solutions with high biocompatible features is a major contributor to the market growth. The development of neutral‐pH, low or ultralow GDP solutions, glucose‐sparing PD solutions, alternative osmotic agents (such as hyperbranched polyglycerol), and low‐sodium PD solutions is driving the segment. North America is expected to observe an incremental growth of close to $900 million by 2025. The region is witnessing a high usage of PD solutions on account of high renal disease prevalence that is increasing the demand for dialysis, especially for hemodialysis peritoneal dialysis.
The increasing preference for peritoneal dialysis that uses the lining of the abdomen or belly to filter the blood inside the body at home and in hospitals and dialysis centers is expected to drive the sale of PD sets. While it becomes costly to order or purchase devices or equipment for the treatment purpose in hospitals, clinics, and dialysis centers, the preference for PD sets, which include the equipment such as specially designed 'Y' shape transfusion sets, is boosting the market growth for peritoneal dialysis market during the forecast period. The Europe PD set market is expected to reach revenue of over $400 million by 2025 due to the prevalence of end-stage chronic kidney disease (CKD) in the elderly population.
INSIGHTS BY TECHNOLOGY
In 2019, the continuous ambulatory peritoneal dialysis (CAPD) segment accounted for over 66% of the global peritoneal dialysis market share. There is an increase in the patient population globally that is boosting PD adoption and is contributing to the CAPD segment growth. Also, the availability of various machines by major and other prominent vendors for CAPD globally is expected to boost the market growth in upcoming years. North America was the major revenue contributor to both CAPD and APD technology segments. However, the APAC region is expected to witness a fast growth rate during the forecast period. Vendors are offering several technologically advanced CAPD products, which is boosting the market demand and contributing to the overall market growth.
The APD segment is likely to witness high absolute growth as end-users are increasingly inclined toward APD due to superior advantages. As a result, vendors are shifting their interest in manufacturing technologically advanced APD products to provide patients with improved quality care and to reduce discomfort in the patient population. Also, the availability of advanced APD products enables caregivers to monitor patients from remote areas and help patients in increasing their mobility with compact devices, thereby offering quality care.
INSIGHTS BY DISEASE
In 2019, the chronic kidney failure (CKF) segment grew at a significant rate, and the trend is likely to continue during the forecast period. The global all-age mortality rate from CKF increased by 41.5% between 1990 and 2017, although there was no significant change in the age-standardized mortality rate. The increasing CKF disease prevalence worldwide is driving the adoption of PD treatment in the patient population that is boosting the market growth. Moreover, the increasing patient population of hypertension and diabetes is driving the prevalence of CKF globally. This has increased the PD adoption in the patient population and dominates the market demand for PD products.
The AKF prevalence is growing due to the increasing COVID-19 cases, according to traces found in China and the US patients in the critical case. There is a growing AKF prevalence that has increased the adoption of dialysis among COVID-19 patients in ICUs, which is likely to boost the market growth for PD during the pandemic situation. Moreover, out of 1.7 million deaths per year caused by AKI globally, around 1.4 million occur in low- and middle-income countries. This is expected to increase the demand for PD in the patient population that is expected to boost the market in developing and developed countries during the forecast period.
INSIGHTS BY END-USERS
The home healthcare settings segment is growing due to the increasing patient population, especially the elderly. As the elderly population is at a higher risk of kidney diseases, there is rising usage of home healthcare settings in the segment. Also, the PD treatment can easily obtain at home as no needle is involved in this process that increases the usage of PD at home healthcare settings, thereby boosting its market growth. The increasing elderly population is leading to chronic disease prevalence, which is expected to boost the peritoneal dialysis market.
The increasing patient population in hospitals and the outbreak of the COVID-9 pandemic are growing the prevalence of AKF as well as CKF, which is boosting the usage of peritoneal dialysis machines as well as other products in hospitals, emergency care centers to treat the COVID-19 patients. The market is likely to boost as dialysis demand in these patients, boosting the PD market in hospitals.
INSIGHTS BY GEOGRAPHY
North America represented the largest regional segment of the market in 2019. The increasing healthcare expenditure in the US and Canada, the growing prevalence of kidney diseases, the growing geriatric population, and the rising incidence of chronic diseases are the factors contributing to the high share of the region. The U.S. dialysis market size is expected to grow on account of the growing end-stage renal diseases in the region. In 2018, there were around 58,027,427 individuals aged 65 years and above in North America. This high number in the region has increased the prevalence of chronic diseases such as CVD, diabetes, obesity, and other ailments. The increasing diabetes patient population in the region is one of the major factors that is increasing the kidney failure incidence, thereby increasing the adoption of PD.
INSIGHTS BY VENDORS
The competitive scenario in the global peritoneal dialysis market is currently intensifying due to the rapidly changing technological environment. This could have a significant impact on the key players as customers expect continual innovations and upgrades, for a better decontamination process. Baxter International, Fresenius Medical Care AG & Co. KGaA, Medionics, and Medtronic are the major vendors in the market. All these companies have a significant presence in major geographical regions such as North America, APAC, and Europe. However, there are many local vendors providing products with similar specifications at lower prices, which has resulted in a price war among vendors. The major vendors are continuously competing among themselves for the leading position in the market, with occasional spurts of competition coming from other local vendors.
The global peritoneal dialysis market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
- PD Solution
- PD Sets
- PD Machines
- PD Catheters
- Chronic Kidney Failure (CKF)
- Acute Kidney Failure (AKF)
- Home Healthcare Settings
- Dialysis Centers
- Nursing Homes
- North America
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia